2020 ESC-ACCA立场声明:急性心肌梗死合并心源性休克的诊断和治疗

2020-03-02 欧洲心脏病学会 Eur Heart J Acute Cardiovasc Care. 2020 Mar 2.

2020年3月,欧洲心脏病学会(ESC)急性心血管病护理协会发布了关于急性心肌梗死合并心源性休克的诊断和治疗声明。该指南总结了目前关于急性心肌梗死合并心源性休克的诊治共识并为临床实践提供指导建议。

中文标题:

2020 ESC-ACCA立场声明:急性心肌梗死合并心源性休克的诊断和治疗

英文标题:

Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European

发布机构:

欧洲心脏病学会

发布日期:

2020-03-02

简要介绍:

2020年3月,欧洲心脏病学会(ESC)急性心血管病护理协会发布了关于急性心肌梗死合并心源性休克的诊断和治疗声明。该指南总结了目前关于急性心肌梗死合并心源性休克的诊治共识并为临床实践提供指导建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=5a6281c0018e6814, title=2020 ESC-ACCA立场声明:急性心肌梗死合并心源性休克的诊断和治疗, enTitle=Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European, guiderFrom=Eur Heart J Acute Cardiovasc Care. 2020 Mar 2., authorId=0, author=, summary=2020年3月,欧洲心脏病学会(ESC)急性心血管病护理协会发布了关于急性心肌梗死合并心源性休克的诊断和治疗声明。该指南总结了目前关于急性心肌梗死合并心源性休克的诊治共识并为临床实践提供指导建议。, cover=https://img.medsci.cn/2020312/1583942719377_2020535.jpg, journalId=0, articlesId=null, associationId=62, associationName=欧洲心脏病学会, associationIntro=是目前在欧洲居于首要地位的心脏病学会,会员超过70000人、提供更新指南、调查数据、组织学术会议,ESC年会是心血管领域最大的会议。下设5个分会(超声心动图学会、心律学会、心衰学会、预防与康复学会及介入学会)。提供指南较全面,按年份排列。现提供有手机板本。, copyright=0, guiderPublishedTime=Mon Mar 02 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年3月,欧洲心脏病学会(ESC)急性心血管病护理协会发布了关于急性心肌梗死合并心源性休克的诊断和治疗声明。该指南总结了目前关于急性心肌梗死合并心源性休克的诊治共识并为临床实践提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=678, tagName=急性心肌梗死), TagDto(tagId=12005, tagName=心源性休克)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=678, guiderKeyword=急性心肌梗死, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4930, appHits=495, showAppHits=18, pcHits=1660, showPcHits=4473, likes=2, shares=27, comments=11, approvalStatus=1, publishedTime=Thu Mar 12 00:05:56 CST 2020, publishedTimeString=2020-03-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Mar 12 00:05:24 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:47:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=971186, encodeId=5d279e1186e1, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/3735a8b9109045f6809c817728c9f793/b38862db756f486594d343f1b2eee40c.jpg, createdBy=6b031353815, createdName=suxiandoctor, createdTime=Sat Jun 05 21:46:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954137, encodeId=896e95413e62, content=受益颇多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/76c7398f9c964a0e933f0a6486f81485/65868560672648cb909fbfaed0739b15.jpg, createdBy=77ea5438296, createdName=ms1000000502953752, createdTime=Tue Apr 06 10:15:23 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920695, encodeId=d26e9206952a, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Thu Jan 28 11:19:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918423, encodeId=cb9f9184235b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d16d2458443, createdName=124105e0m30暂无昵称, createdTime=Wed Jan 20 15:30:35 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914956, encodeId=89ca914956df, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Sat Jan 09 19:47:18 CST 2021, time=2021-01-09, status=1, ipAttribution=)]
    2021-06-05 suxiandoctor

    学习下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=971186, encodeId=5d279e1186e1, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/3735a8b9109045f6809c817728c9f793/b38862db756f486594d343f1b2eee40c.jpg, createdBy=6b031353815, createdName=suxiandoctor, createdTime=Sat Jun 05 21:46:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954137, encodeId=896e95413e62, content=受益颇多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/76c7398f9c964a0e933f0a6486f81485/65868560672648cb909fbfaed0739b15.jpg, createdBy=77ea5438296, createdName=ms1000000502953752, createdTime=Tue Apr 06 10:15:23 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920695, encodeId=d26e9206952a, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Thu Jan 28 11:19:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918423, encodeId=cb9f9184235b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d16d2458443, createdName=124105e0m30暂无昵称, createdTime=Wed Jan 20 15:30:35 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914956, encodeId=89ca914956df, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Sat Jan 09 19:47:18 CST 2021, time=2021-01-09, status=1, ipAttribution=)]
    2021-04-06 ms1000000502953752

    受益颇多

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=971186, encodeId=5d279e1186e1, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/3735a8b9109045f6809c817728c9f793/b38862db756f486594d343f1b2eee40c.jpg, createdBy=6b031353815, createdName=suxiandoctor, createdTime=Sat Jun 05 21:46:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954137, encodeId=896e95413e62, content=受益颇多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/76c7398f9c964a0e933f0a6486f81485/65868560672648cb909fbfaed0739b15.jpg, createdBy=77ea5438296, createdName=ms1000000502953752, createdTime=Tue Apr 06 10:15:23 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920695, encodeId=d26e9206952a, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Thu Jan 28 11:19:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918423, encodeId=cb9f9184235b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d16d2458443, createdName=124105e0m30暂无昵称, createdTime=Wed Jan 20 15:30:35 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914956, encodeId=89ca914956df, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Sat Jan 09 19:47:18 CST 2021, time=2021-01-09, status=1, ipAttribution=)]
    2021-01-28 ms2000000057946177

    学习啦

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=971186, encodeId=5d279e1186e1, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/3735a8b9109045f6809c817728c9f793/b38862db756f486594d343f1b2eee40c.jpg, createdBy=6b031353815, createdName=suxiandoctor, createdTime=Sat Jun 05 21:46:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954137, encodeId=896e95413e62, content=受益颇多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/76c7398f9c964a0e933f0a6486f81485/65868560672648cb909fbfaed0739b15.jpg, createdBy=77ea5438296, createdName=ms1000000502953752, createdTime=Tue Apr 06 10:15:23 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920695, encodeId=d26e9206952a, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Thu Jan 28 11:19:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918423, encodeId=cb9f9184235b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d16d2458443, createdName=124105e0m30暂无昵称, createdTime=Wed Jan 20 15:30:35 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914956, encodeId=89ca914956df, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Sat Jan 09 19:47:18 CST 2021, time=2021-01-09, status=1, ipAttribution=)]
    2021-01-20 124105e0m30暂无昵称

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=971186, encodeId=5d279e1186e1, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/3735a8b9109045f6809c817728c9f793/b38862db756f486594d343f1b2eee40c.jpg, createdBy=6b031353815, createdName=suxiandoctor, createdTime=Sat Jun 05 21:46:05 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954137, encodeId=896e95413e62, content=受益颇多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/76c7398f9c964a0e933f0a6486f81485/65868560672648cb909fbfaed0739b15.jpg, createdBy=77ea5438296, createdName=ms1000000502953752, createdTime=Tue Apr 06 10:15:23 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920695, encodeId=d26e9206952a, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Thu Jan 28 11:19:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918423, encodeId=cb9f9184235b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d16d2458443, createdName=124105e0m30暂无昵称, createdTime=Wed Jan 20 15:30:35 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914956, encodeId=89ca914956df, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Sat Jan 09 19:47:18 CST 2021, time=2021-01-09, status=1, ipAttribution=)]
    2021-01-09 ltxdsr810920

    学习了

    0

拓展阅读

新型冠状病毒肺炎防控形势下急性心肌梗死诊治流程和路径中国专家共识(第1版)

中国医师协会心血管内科医师分会(CCCP,Chinese College of Cardiovascular Physicians) · 2020-02-12

2020 KSMI专家共识:急性心肌梗死的药物治疗

国外心血管相关专家小组(统称) · 2020-09-20

2020 AACA意见书:急性心肌梗死的质量指标

急性心血管保健协会(AACA,Acute Cardiovascular Care Association) · 2021-02-07

2020 AACA/ESC意见书:急性心肌梗死凝血和纤溶生物标志物

急性心血管保健协会(AACA,Acute Cardiovascular Care Association) · 2020-11-07

2021 AHA科学声明:急性心肌梗死合并心源性休克的介入治疗

美国心脏协会(AHA,American Heart Association) · 2021-03-04

急性心肌梗死中医临床诊疗指南

暂未更新 · 2021-07-08